Alongside this, it was revealed that long-term TNF-α treatment reduces the Pgp/ABCB1 transcript and protein levels in intrinsically Pgp-positive colon cancer cells, promoting sensitivity to chemotherapeutic drugs and, possibly, MDR reversal. This evidence concerns the gene PGP and colonic neoplasm.